| Target Price | $586.50 |
| Price | $259.86 |
| Potential |
125.70%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target Praxis Precision Medicines Inc 2027 .
The average Praxis Precision Medicines Inc target price is $586.50.
This is
125.70%
register free of charge
$1,261.05
385.28%
register free of charge
$189.88
26.93%
register free of charge
|
|
| A rating was issued by 25 analysts: 22 Analysts recommend Praxis Precision Medicines Inc to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Praxis Precision Medicines Inc stock has an average upside potential 2027 of
125.70%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 06 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 06 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 24 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Sep 24 2026 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 06 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 06 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 24 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Sep 24 2026 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 07 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


